ANI Pharmaceuticals Inc

ANIP · Moat type: REGULIERUNG
MoatScore
6/10
Fair Value
199 USD
Margin of Safety
+58.8 %
Rating
BEOBACHTEN
ANI Pharmaceuticals develops, manufactures and markets a broad portfolio of generic and specialty pharmaceuticals — including regulated, short-supply-capable products and rare disease treatments — and generates revenues through license-based marketing as well as a proprietary development pipeline in a regulatory-protected market environment.
View full analysis →
🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.